Bronchiectasis is a chronic lung condition where the airways (bronchial tubes) become permanently widened and damaged, making it difficult to clear mucus. This trapped mucus creates a breeding ground for bacteria, leading to repeated infections that cause further damage over time. In the United States, roughly 194 to 404 people per 100,000 have the condition depending on how strictly it’s defined, and those numbers have been climbing over the past decade.
What Happens Inside the Lungs
Your bronchial tubes are lined with elastic tissue, muscle, and cartilage that give them their shape and flexibility. In bronchiectasis, repeated infections or inflammation destroy the elastic layer of the airway walls and, to a lesser extent, damage the muscle and cartilage layers. The result is airways that stretch out and lose their ability to snap back to normal size. Think of it like a rubber band that’s been pulled too many times: it stays loose.
Healthy airways are coated with a thin layer of mucus and lined with tiny hair-like structures that sweep mucus upward toward the throat, where it can be swallowed or coughed out. When the airways are stretched and scarred, this cleaning system breaks down. Mucus pools in the widened pockets, bacteria multiply, and the immune system responds with inflammation. That inflammation causes more damage, which traps more mucus, which feeds more bacteria. Pulmonary researchers call this self-reinforcing loop the “vicious vortex” because each component, infection, inflammation, impaired mucus clearance, and structural damage, makes all the others worse simultaneously. This is also why treatments targeting just one part of the cycle often don’t produce dramatic improvements on their own.
Common Causes
Bronchiectasis develops when something damages the airway walls badly enough, or often enough, that the damage becomes permanent. The trigger varies from person to person, and in some cases, no clear cause is ever identified.
Severe or repeated lung infections are the most common culprit. In past decades, childhood infections like whooping cough and measles were leading causes in the U.S. Today, a bad bout of pneumonia or tuberculosis can set the stage. Immune system disorders also play a significant role: conditions that weaken your body’s ability to fight infection make the lungs vulnerable to the kind of repeated damage that leads to permanent airway widening.
Several other conditions raise the risk. COPD, asthma, and gastroesophageal reflux disease (GERD) are associated with bronchiectasis in adults. So are autoimmune and connective tissue diseases like rheumatoid arthritis, Sjögren’s syndrome, and inflammatory bowel disease (including Crohn’s disease). Cystic fibrosis, a genetic condition, causes its own distinct form of bronchiectasis, but the majority of cases fall into the “non-cystic fibrosis” category.
What Bronchiectasis Feels Like
The hallmark symptom is a daily cough that produces large amounts of sputum, a mix of mucus, saliva, and sometimes pus. This isn’t an occasional morning cough. It persists for at least eight weeks and often becomes a permanent part of daily life. The mucus can smell bad and may change in color or thickness during flare-ups.
Beyond the cough, you may notice shortness of breath, wheezing, and frequent colds or respiratory infections that seem to come back no matter what you do. Over time, more serious symptoms can develop, including coughing up blood or bloody mucus and deep, persistent fatigue.
Flare-Ups (Exacerbations)
People with bronchiectasis go through periods where their symptoms worsen significantly. A clinical exacerbation is generally defined as a worsening of at least three key symptoms for 48 hours or more: increased cough, changes in mucus volume or thickness, more purulent (pus-filled) sputum, greater breathlessness, fatigue, or new episodes of coughing up blood. Exacerbations typically require a change in treatment, often a course of antibiotics.
During a flare-up, you may also experience fever, chills, night sweats, and extreme tiredness that goes well beyond your baseline. The frequency of exacerbations varies widely. Some people have one or two a year, others have several. Each exacerbation carries the risk of causing additional, irreversible airway damage, so recognizing the signs early matters.
How It’s Diagnosed
A high-resolution CT scan of the chest is the standard tool for confirming bronchiectasis. On these detailed images, doctors compare the width of each airway to the blood vessel running alongside it. In healthy lungs, the airway and its companion artery are roughly the same size. The most widely used diagnostic threshold is an airway-to-artery ratio greater than 1.0, meaning the airway is visibly wider than it should be. This criterion is used in about 42% of studies, though it has not been formally validated through large-scale trials.
Lung function testing (spirometry) is also part of the workup, but the results are less straightforward than you might expect. Bronchiectasis can show up as an obstructive pattern (difficulty pushing air out), a restrictive pattern (reduced lung capacity), or completely normal readings. Obstructive and restrictive patterns tend to correlate with more severe disease and a higher rate of hospitalizations. Once bronchiectasis is confirmed, doctors often run additional tests to look for an underlying cause, including bloodwork to check immune function and screening for conditions like cystic fibrosis or autoimmune diseases.
Treatment and Daily Management
There is no cure for bronchiectasis, so treatment focuses on slowing the vicious vortex: clearing mucus, reducing infections, and controlling inflammation. For most people, this means a combination of airway clearance techniques and medications.
Airway clearance is the backbone of daily management. This includes techniques like chest physiotherapy, where specific breathing exercises and body positions help gravity and vibration move mucus out of the widened airways. Many people use handheld devices that create oscillating pressure to loosen mucus, making it easier to cough up. Doing this consistently, often once or twice a day, helps prevent the mucus buildup that feeds the infection cycle.
On the medication side, long-term low-dose antibiotics are sometimes prescribed to reduce the frequency of exacerbations. European guidelines recommend a specific class of antibiotics called macrolides for ongoing use in patients who experience frequent flare-ups. When an acute exacerbation hits, a more targeted antibiotic course is usually needed, chosen based on what bacteria are found in sputum cultures. Inhaled bronchodilators (the same type of medications used in asthma) can help open the airways before clearance sessions.
Staying active is important. Regular exercise improves lung function, helps move mucus, and builds the kind of cardiovascular reserve that makes daily life with bronchiectasis more manageable. Pulmonary rehabilitation programs, which combine supervised exercise with education, are an option for people whose symptoms limit their activity level. Keeping up with flu and pneumonia vaccinations also reduces the risk of infections that could trigger exacerbations and cause further lung damage.
Long-Term Outlook
Bronchiectasis is a lifelong condition, but its progression varies enormously. Some people maintain stable lung function for years with consistent daily management. Others, particularly those with frequent exacerbations or an underlying immune disorder, experience a more rapid decline. The key variable is breaking the cycle: fewer infections mean less inflammation, which means less structural damage, which means better mucus clearance. Each part of the loop you can improve takes pressure off the rest.
Complications can develop over time. Repeated infections may gradually reduce lung capacity. Coughing up significant amounts of blood, while uncommon, requires urgent medical attention. In advanced cases, the heart can be strained by chronically low oxygen levels, a condition called cor pulmonale. Early diagnosis and consistent daily treatment are the most effective tools for keeping the disease from reaching that point.